These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 11302725

  • 1. Effect of angiotensin II type 2 receptor on tyrosine kinase Pyk2 and c-Jun NH2-terminal kinase via SHP-1 tyrosine phosphatase activity: evidence from vascular-targeted transgenic mice of AT2 receptor.
    Matsubara H, Shibasaki Y, Okigaki M, Mori Y, Masaki H, Kosaki A, Tsutsumi Y, Uchiyama Y, Fujiyama S, Nose A, Iba O, Tateishi E, Hasegawa T, Horiuchi M, Nahmias C, Iwasaka T.
    Biochem Biophys Res Commun; 2001 Apr 20; 282(5):1085-91. PubMed ID: 11302725
    [Abstract] [Full Text] [Related]

  • 2. Regulation of calcium-sensitive tyrosine kinase Pyk2 by angiotensin II in endothelial cells. Roles of Yes tyrosine kinase and tyrosine phosphatase SHP-2.
    Tang H, Zhao ZJ, Landon EJ, Inagami T.
    J Biol Chem; 2000 Mar 24; 275(12):8389-96. PubMed ID: 10722671
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin II type 2 receptor inhibits epidermal growth factor receptor transactivation by increasing association of SHP-1 tyrosine phosphatase.
    Shibasaki Y, Matsubara H, Nozawa Y, Mori Y, Masaki H, Kosaki A, Tsutsumi Y, Uchiyama Y, Fujiyama S, Nose A, Iba O, Tateishi E, Hasegawa T, Horiuchi M, Nahmias C, Iwasaka T.
    Hypertension; 2001 Sep 24; 38(3):367-72. PubMed ID: 11566906
    [Abstract] [Full Text] [Related]

  • 4. Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell.
    Cui T, Nakagami H, Iwai M, Takeda Y, Shiuchi T, Daviet L, Nahmias C, Horiuchi M.
    Cardiovasc Res; 2001 Mar 24; 49(4):863-71. PubMed ID: 11230986
    [Abstract] [Full Text] [Related]

  • 5. Adenovirus-mediated overexpression and stimulation of the human angiotensin II type 2 receptor in porcine cardiac fibroblasts does not modulate proliferation, collagen I mRNA expression and ERK1/ERK2 activity, but inhibits protein tyrosine phosphatases.
    Warnecke C, Kaup D, Marienfeld U, Poller W, Yankah C, Gräfe M, Fleck E, Regitz-Zagrosek V.
    J Mol Med (Berl); 2001 Sep 24; 79(9):510-21. PubMed ID: 11692164
    [Abstract] [Full Text] [Related]

  • 6. Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II.
    Ohtsu H, Mifune M, Frank GD, Saito S, Inagami T, Kim-Mitsuyama S, Takuwa Y, Sasaki T, Rothstein JD, Suzuki H, Nakashima H, Woolfolk EA, Motley ED, Eguchi S.
    Arterioscler Thromb Vasc Biol; 2005 Sep 24; 25(9):1831-6. PubMed ID: 15994438
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase.
    Bedecs K, Elbaz N, Sutren M, Masson M, Susini C, Strosberg AD, Nahmias C.
    Biochem J; 1997 Jul 15; 325 ( Pt 2)(Pt 2):449-54. PubMed ID: 9230127
    [Abstract] [Full Text] [Related]

  • 8. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.
    Masaki H, Kurihara T, Yamaki A, Inomata N, Nozawa Y, Mori Y, Murasawa S, Kizima K, Maruyama K, Horiuchi M, Dzau VJ, Takahashi H, Iwasaka T, Inada M, Matsubara H.
    J Clin Invest; 1998 Feb 01; 101(3):527-35. PubMed ID: 9449684
    [Abstract] [Full Text] [Related]

  • 9. Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation.
    Kyaw M, Yoshizumi M, Tsuchiya K, Kagami S, Izawa Y, Fujita Y, Ali N, Kanematsu Y, Toida K, Ishimura K, Tamaki T.
    Mol Pharmacol; 2004 Apr 01; 65(4):832-41. PubMed ID: 15044612
    [Abstract] [Full Text] [Related]

  • 10. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
    Godeny MD, Sayyah J, VonDerLinden D, Johns M, Ostrov DA, Caldwell-Busby J, Sayeski PP.
    Cell Signal; 2007 Mar 01; 19(3):600-9. PubMed ID: 17027227
    [Abstract] [Full Text] [Related]

  • 11. Cross-talk between angiotensin II receptors and the tyrosine kinases and phosphatases.
    Inagami T, Eguchi S, Numaguchi K, Motley ED, Tang H, Matsumoto T, Yamakawa T.
    J Am Soc Nephrol; 1999 Jan 01; 10 Suppl 11():S57-61. PubMed ID: 9892141
    [Abstract] [Full Text] [Related]

  • 12. Analysis of functional domains of angiotensin II type 2 receptor involved in apoptosis.
    Lehtonen JY, Daviet L, Nahmias C, Horiuchi M, Dzau VJ.
    Mol Endocrinol; 1999 Jul 01; 13(7):1051-60. PubMed ID: 10406457
    [Abstract] [Full Text] [Related]

  • 13. Differential role of angiotensin II receptor subtypes on endothelial superoxide formation.
    Sohn HY, Raff U, Hoffmann A, Gloe T, Heermeier K, Galle J, Pohl U.
    Br J Pharmacol; 2000 Oct 01; 131(4):667-72. PubMed ID: 11030714
    [Abstract] [Full Text] [Related]

  • 14. Role of AT1 and AT2 receptors in regulation of MAPKs and MKP-1 by ANG II in adult cardiac myocytes.
    Fischer TA, Singh K, O'Hara DS, Kaye DM, Kelly RA.
    Am J Physiol; 1998 Sep 01; 275(3):H906-16. PubMed ID: 9724295
    [Abstract] [Full Text] [Related]

  • 15. Regulation of collagen synthesis in mouse skin fibroblasts by distinct angiotensin II receptor subtypes.
    Min LJ, Cui TX, Yahata Y, Yamasaki K, Shiuchi T, Liu HW, Chen R, Li JM, Okumura M, Jinno T, Wu L, Iwai M, Nahmias C, Hashimoto K, Horiuchi M.
    Endocrinology; 2004 Jan 01; 145(1):253-60. PubMed ID: 14551224
    [Abstract] [Full Text] [Related]

  • 16. Calcium- and protein kinase C-dependent activation of the tyrosine kinase PYK2 by angiotensin II in vascular smooth muscle.
    Sabri A, Govindarajan G, Griffin TM, Byron KL, Samarel AM, Lucchesi PA.
    Circ Res; 1998 Oct 19; 83(8):841-51. PubMed ID: 9776731
    [Abstract] [Full Text] [Related]

  • 17. Unique regulation of c-Jun N-terminal kinase by PYK2/CAK-beta in angiotensin II-stimulated vascular smooth muscle cells.
    Frank GD, Eguchi S, Motley ED, Sasaki T, Inagami T.
    Biochem Biophys Res Commun; 2001 Aug 31; 286(4):692-6. PubMed ID: 11520052
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of tumor necrosis factor-[alpha]-induced SHP-2 phosphatase activity by shear stress: a mechanism to reduce endothelial inflammation.
    Lerner-Marmarosh N, Yoshizumi M, Che W, Surapisitchat J, Kawakatsu H, Akaike M, Ding B, Huang Q, Yan C, Berk BC, Abe J.
    Arterioscler Thromb Vasc Biol; 2003 Oct 01; 23(10):1775-81. PubMed ID: 12947019
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin II-induced neural differentiation via angiotensin II type 2 (AT2) receptor-MMS2 cascade involving interaction between AT2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1.
    Li JM, Mogi M, Tsukuda K, Tomochika H, Iwanami J, Min LJ, Nahmias C, Iwai M, Horiuchi M.
    Mol Endocrinol; 2007 Feb 01; 21(2):499-511. PubMed ID: 17068200
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin II initiates tyrosine kinase Pyk2-dependent signalings leading to activation of Rac1-mediated c-Jun NH2-terminal kinase.
    Murasawa S, Matsubara H, Mori Y, Masaki H, Tsutsumi Y, Shibasaki Y, Kitabayashi I, Tanaka Y, Fujiyama S, Koyama Y, Fujiyama A, Iba S, Iwasaka T.
    J Biol Chem; 2000 Sep 01; 275(35):26856-63. PubMed ID: 10856308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.